News for Ekso Bionics Holdings, Inc. (EKSO)

Ekso Bionics looks to sell 10.5 million shares of its common stock, suggesting strategic moves by existing stakeholders. Analyst price targets for EKSO

Shares of Chanson International Holding CHSN rose sharply in today's pre-market trading after reported a year-over-year increase in FY24 financial results. Cha...

Release Date: March 03, 2025For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Ekso Bionics Ho

SAN RAFAEL, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. ( EKSO) (”œEkso Bionics” or the ”œCompany”), an industry leader in ex

**media[556076]**

SAN RAFAEL, Calif., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. ( EKSO) (the ”œCompany”), an industry leader in exoskeleton technology fo

Transaction Overview On December 31, 2024, ARMISTICE CAPITAL, LLC (Trades, Portfolio) executed a strategic transaction involving Ekso Bionics Holdings Inc. The

On December 31, 2024, Kent Lake PR LLC (Trades, Portfolio) made a significant move by reducing its position in Ekso Bionics Holdings Inc (EKSO). The firm decrea

**media[536544]**

Move expected to broaden access to Ekso Bionics' portable exoskeleton device for individuals living with spinal cord injuries and other mobility challenges acr

Expects Record Revenues for the Fourth Quarter of 2024 SAN RAFAEL, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. ( EKSO) (the ”œComp

Meihua International (MHUA) experienced a significant stock movement, with its shares rising by 5.16%. The stock is currently priced at $0.379 per share, with a

Global AI in Rehabilitation and Assistive Technologies Market Worth $5.61 Bn by 2031 — Exclusive Report by InsightAce Analytic Pvt. Ltd. InsightAce Analytic Pvt. Ltd. announces the release of a…

Ekso Bionics stock plunges to 52-week low of $0.71

Ekso Bionics stock hits 52-week low at $0.83 amid market challenges

According to Research by SNS Insider, The Medical Robots Market Growth is Driven by Technological Advances, Demand for Minimally Invasive Surgeries, and...

Quarterly Sales: $4.1 million in Q3 2024, down from $4.6 million in Q3 2023.Gross Margin: 53.5% in Q3 2024, slightly up from 53.3% in Q3 2023.Operating Expense

Oct 28, 2024 / 08:30PM GMTOperator Greetings and welcome to the Ekso Bionics quarter 3, 2024 financial results call. (Operator Instructions) As a reminder this

The Soft Robotics Market has seen remarkable growth, with its value standing at USD 0.6 billion in 2023. By 2033, it is expected to surge to USD 8.5 billion, growing at a compound annual growth rate…